Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 481,943 | 154,600 | 124,113 | 102,055 | 107,598 |
| Marketable Securities | N/A | N/A | 11,286 | N/A | N/A |
| Receivables | 171,126 | 171,323 | 158,234 | 148,186 | 140,750 |
| Inventories | 232,340 | 234,680 | 239,809 | 217,263 | 219,671 |
| TOTAL | $944,943 | $616,166 | $568,919 | $495,170 | $511,877 |
| Non-Current Assets | |||||
| PPE Net | 232,241 | 232,074 | 229,110 | 222,369 | 212,195 |
| Intangibles | 1,221,995 | 1,234,154 | 1,232,637 | 1,071,746 | 1,089,323 |
| Other Non-Current Assets | 19,008 | 18,737 | 18,349 | 18,669 | 14,029 |
| TOTAL | $1,473,244 | $1,484,965 | $1,480,096 | $1,312,784 | $1,315,547 |
| Total Assets | $2,418,187 | $2,101,131 | $2,049,015 | $1,807,954 | $1,827,424 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 12,500 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 40,740 | 42,193 | 45,594 | 29,057 | 38,932 |
| Accrued Expenses | 143,076 | 114,760 | 91,105 | 87,732 | 86,718 |
| Other current liabilities | N/A | N/A | 37,046 | N/A | N/A |
| TOTAL | $210,234 | $177,877 | $188,083 | $123,601 | $161,397 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,152,633 | 867,500 | 848,750 | 665,000 | 433,750 |
| Deferred Revenues | 7,668 | 8,424 | 8,088 | 6,812 | 6,997 |
| Other Non-Current Liabilities | 13,576 | 29,944 | 28,855 | 30,745 | 255,478 |
| TOTAL | $1,294,837 | $1,028,699 | $1,008,441 | $844,686 | $842,600 |
| Total Liabilities | $1,505,071 | $1,206,576 | $1,196,524 | $968,287 | $1,003,997 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,477 | 78,078 | 75,621 | 74,816 | 74,772 |
| Common Shares | 813 | 804 | 782 | 777 | 463 |
| Retained earnings | 240,831 | 237,673 | 226,837 | 220,443 | 192,195 |
| Other shareholders' equity | -23,599 | -34,172 | -51,504 | -57,205 | -40,431 |
| TOTAL | $913,116 | $894,555 | $852,491 | $839,667 | $823,427 |
| Total Liabilities And Equity | $2,418,187 | $2,101,131 | $2,049,015 | $1,807,954 | $1,827,424 |